REFERENCES
- Telfer P, Coen PG, Christou S, et al. Survival of medically treated thalassaemia patients in Cyprus. Trends and risk factors over the period 1980–2004. Haematological. 2006;91(9):1187–1192.
- Borgna-Pignatti C. Surviving with thalassemia major: the Italian experience. Pediatr Hematol Oncol 2007;24(1):75–78.
- Centres of reference for rare diseases in Europe: state of the art in 2006 and recommendations of the rare disease task force. Available at: http://ec.europa.eu/health/ph_threats/non_com/docs/contribution_policy.pdf
- Old J, Traeger-Synodinos J, Galanello R, Petrou M, Angastiniotis M. Prevention of Thalassaemia and Other Haemoglobinopathies. Vols. 1 and 2. Cyprus: TIF Publications; 2005.
- Cappellini MD, Cohen A, Eleftheriou A, Piga A, Porter J, Taher A. Guidelines for the Clinical Management of Thalassaemia. 2nd ed. (revised) Cyprus: TIF Publications; 2008.
- Wagner EH, Austin BT, Davis C, et al. Improving chronic illness care: translating evidence into action. Health Aff (Millwood). 2001;20:64–78.
- Epping-Jordan JE, Pruitt SD, Bengoa R, Wagner EH. Improving the quality of care for chronic conditions. Qual Saf Health Care. 2004;13:299–305.
- World Health Organization. Innovative Care for Chronic Conditions: Building Blocks for Action. Geneva: WHO; 2002.